Showing 2051-2060 of 2735 results for "".
- New AAFPRS Data: Social Media Makes Lasting Impact on Industryhttps://modernaesthetics.com/news/new-aafprs-data-social-media-makes-lasting-impact-on-industry/2472141/Like it or not, the selfie and its impact on aesthetics is here to stay, and continues to have a huge effect on how we perceive and project ourselves in front of the camera and off. This is among the main findings from the annual survey of the
- Milestone Scientific Gears Up To Launch New Botox Delivery Instrumenthttps://modernaesthetics.com/news/milestone-scientific-gears-up-to-launch-new-botox-delivery-instrument/2472162/Botulinum toxin injections may be about to get smarter and more comfortable as Milestone Scientific Inc. readies to launch its novel and proprietary cosmetic injection instrument. The new cosmetic injection instrument
- New AAFPRS Data: More Than 30 Percent of Men Are Considering Nips and Tuckshttps://modernaesthetics.com/news/new-aafprs-data-more-than-30-percent-of-men-are-considering-nips-and-tucks/2472223/The plastic surgery ‘menaissaince’ may really be a thing, finds a new survey from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). It turns out that 31 percent of men said they are “extremely likely&rdq
- Read Their Lips: Avoid Unnatural Lip Enhancement Results With This Datahttps://modernaesthetics.com/news/read-their-lips-avoid-unnatural-lip-enhancement-results-with-this-data/2472247/Many a Real Housewife from Bravo’s hit reality TV franchise have been chastised for trout pout – or an overfilled, unnatural looking pucker. And now a new study, published by JAMA Facial
- Survey: Many Bothered By Double Chins, Take Steps To Cover Uphttps://modernaesthetics.com/news/survey-many-bothered-by-double-chins-take-steps-to-cover-up/2472259/Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc.<
- Galderma Rolls Out Restylane Refyne, Defynehttps://modernaesthetics.com/news/galderma-rolls-out-restylane-refyne-defyne/2472262/With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --
- BTL Aesthetics Unveils New Ultra Femme 360° Technology for Vaginal Rejuvenationhttps://modernaesthetics.com/news/btl-aesthetics-unveils-new-ultra-femme-360-technology-for-vaginal-rejuvenation/2472265/BTL Industries is introducing its new 360° technology to leading cosmetic dermatologists and physicians during the annual American Academy of Dermatology (AAD) Conference taking place in Orlando, FL, March 3rd – 7th, with th
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- Study Evaluates Buccal Fat Pad Flap in Complex Facial Reconstructionhttps://modernaesthetics.com/news/study-evaluates-buccal-fat-pad-flap-in-complex-facial-reconstruction/2486791/A prospective cohort study published online in Aesthetic Plastic Surgery evaluated the reconstructive utility of the buccal fat pad flap in patients undergoing permanent filler removal followed by deep plane facelift. Conducted at a single center in Cairo between 2016 and 2022, the study
- Cell-Assisted Lipotransfer Shows Potential in Facial and Breast Applications, Review Findshttps://modernaesthetics.com/news/cell-assisted-lipotransfer-shows-potential-in-facial-and-breast-applications-review-finds/2486650/Cell-assisted lipotransfer (CAL) continues to evolve as an adjunct to conventional fat grafting, with a recent review in Annali Italiani di Chirurgia summarizing current evidence for its use in facial and breast procedures. CAL involves enrichment of autologous fat grafts with regenerati